Quintiles Restructuring To Move Drug Development Process Online
Executive Summary
Quintiles will convert all aspects of its drug development process, including clinical trial recruitment and physician payment, into web transactions by 2002, the firm indicated during a Jan. 24 conference call announcing its Internet partnership with Healtheon/WebMD.
You may also be interested in...
Quintiles Expects Expanded Services Contribution To CSO To Be 50% By 2005
Quintiles' expanded non-traditional services will account for roughly 50% of the company's contract sales revenues by the end of 2005 following a reorganization effort, Quintiles predicts.
Quintiles Expects Expanded Services Contribution To CSO To Be 50% By 2005
Quintiles' expanded non-traditional services will account for roughly 50% of the company's contract sales revenues by the end of 2005 following a reorganization effort, Quintiles predicts.
Covance Tissue Sample Stockpile Is Possible Asset For Genomics Research
Covance sees its stockpile of tissue samples from past clinical trials as a potential asset for building a genomics testing business in the future, the clinical research organization indicated during its second quarter earnings conference call July 26.